BeOne Medicines (ONC) Research & Development (2016 - 2025)
Historic Research & Development for BeOne Medicines (ONC) over the last 11 years, with Q3 2025 value amounting to $523.7 million.
- BeOne Medicines' Research & Development rose 553.89% to $523.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 billion, marking a year-over-year increase of 877.5%. This contributed to the annual value of $2.0 billion for FY2024, which is 982.24% up from last year.
- According to the latest figures from Q3 2025, BeOne Medicines' Research & Development is $523.7 million, which was up 553.89% from $524.9 million recorded in Q2 2025.
- In the past 5 years, BeOne Medicines' Research & Development registered a high of $542.0 million during Q4 2024, and its lowest value of -$556.3 million during Q4 2021.
- Its 5-year average for Research & Development is $388.2 million, with a median of $446.0 million in 2022.
- Per our database at Business Quant, BeOne Medicines' Research & Development crashed by 25646.44% in 2021 and then soared by 18017.83% in 2022.
- BeOne Medicines' Research & Development (Quarter) stood at -$556.3 million in 2021, then surged by 180.18% to $446.0 million in 2022, then rose by 10.75% to $494.0 million in 2023, then grew by 9.72% to $542.0 million in 2024, then dropped by 3.39% to $523.7 million in 2025.
- Its last three reported values are $523.7 million in Q3 2025, $524.9 million for Q2 2025, and $481.9 million during Q1 2025.